Skip to main content
SpringerLink
Log in

Upadacitinib increases risk of herpes zoster and NMSC

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Fleischmann R, et al. Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme. Annals of the Rheumatic Diseases : 12 Jun 2023. Available from: URL: http://doi.org/10.1136/ard-2023-223916

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Upadacitinib increases risk of herpes zoster and NMSC. Reactions Weekly 1962, 12 (2023). https://doi.org/10.1007/s40278-023-41682-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-41682-z

Search

Navigation